SEATTLE, Feb. 26 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009 (the “Annual Report on Form 10-K”). This filing is available for review on CTI’s website at www.CellTherapeutics.com, or on the Securities and Exchange Commission’s website at www.sec.gov.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.
Cell Therapeutics, Inc.
